Patents Assigned to Doasense GmbH
  • Determination of direct thrombin inhibitors in fluids like serum or urine
    Patent number: 9944971
    Abstract: The present invention relates to a method for detecting at least one direct thrombin inhibitor in a sample other than citrate plasma, comprising the step of mixing a sample containing a thrombin inhibitor with a composition containing thrombin under conditions which allow the thrombin to release a detectable substance from a chromogenic substrate.
    Type: Grant
    Filed: June 15, 2012
    Date of Patent: April 17, 2018
    Assignee: DOASENSE GmbH
    Inventors: Job Harenberg, Roland Kramer
  • Analysis of direct factor Xa inhibitors
    Patent number: 9897617
    Abstract: The present invention relates to a method for detecting at least one direct factor Xa inhibitor in a sample other than citrate plasma, comprising the step of mixing a sample containing a factor Xa inhibitor with a composition containing factor Xa under conditions which allow the factor Xa to release a detectable substance from a chromogenic substrate.
    Type: Grant
    Filed: August 11, 2015
    Date of Patent: February 20, 2018
    Assignee: Doasense GmbH
    Inventors: Job Harenberg, Roland Krämer
  • Analysis of direct factor Xa inhibitors
    Patent number: 9810701
    Abstract: The present invention relates to a method for detecting at least one direct factor Xa inhibitor in a sample other than citrate plasma, comprising the step of mixing a sample containing a factor Xa inhibitor with a composition containing factor Xa under conditions which allow the factor Xa to release a detectable substance from a chromogenic substrate.
    Type: Grant
    Filed: August 11, 2015
    Date of Patent: November 7, 2017
    Assignee: Doasense GmbH
    Inventors: Job Harenberg, Roland Krämer